Multiple Sclerosis vs. Reactive Arthritis: What Are the Differences?

Multiple Sclerosis vs. Reactive Arthritis: What Are the Differences?ByLana BarhumPublished on July 04, 2022Medically reviewed byDavid Ozeri, MDMultiple sclerosis (MS) and

Updated on: June 12,2024

Multiple Sclerosis vs. Reactive Arthritis: What Are the Differences?

Multiple Sclerosis vs. Reactive Arthritis: What Are the Differences?ByLana BarhumPublished on July 04, 2022Medically reviewed byDavid Ozeri, MDMultiple sclerosis (MS) and

Updated on:June 12,2024

Researchers identify mutation that alters Alzheimer's disease progression

by University of MalagaResearchers identify a mutation that alters Alzheimer's disease progression. The UMA coordinates this study, carried out by 100 multidisciplinary researchers from 50 di

Updated on: March 20,2024

Researchers identify mutation that alters Alzheimer's disease progression

by University of MalagaResearchers identify a mutation that alters Alzheimer's disease progression. The UMA coordinates this study, carried out by 100 multidisciplinary researchers from 50 di

Updated on:March 20,2024

First study of the microvessels connecting the human cranium and brain

by CENIEHMicrophoramine distribution in adult human skulls. Credit: Bruner and EisovaEmiliano Bruner, a paleoneurologist at the Centro Nacional de Investigación sobre la Evolución Humana (CENIEH), has

Updated on: March 19,2024

First study of the microvessels connecting the human cranium and brain

by CENIEHMicrophoramine distribution in adult human skulls. Credit: Bruner and EisovaEmiliano Bruner, a paleoneurologist at the Centro Nacional de Investigación sobre la Evolución Humana (CENIEH), has

Updated on:March 19,2024

Researchers find possible neuromarker for 'juvenile-onset' Batten disease

by Kelsie Smith Hayduk,University of Rochester Medical CenterMeanMMN amplitude for each SOA in TD and CLN3 disease groups. Each scatter plot, box plot, and violin plot column represents in

Updated on: January 09,2024

Researchers find possible neuromarker for 'juvenile-onset' Batten disease

by Kelsie Smith Hayduk,University of Rochester Medical CenterMeanMMN amplitude for each SOA in TD and CLN3 disease groups. Each scatter plot, box plot, and violin plot column represents in

Updated on:January 09,2024

Global dementia cases set to triple by 2050 unless countries address risk factors

by LancetCredit: Pixabay/CC0 Public DomainThe number of adults (aged 40 years and older) living with dementia worldwide is expected to nearly triple, from an estimated 57 million in 2019 to 153 m

Updated on: May 13,2024

Global dementia cases set to triple by 2050 unless countries address risk factors

by LancetCredit: Pixabay/CC0 Public DomainThe number of adults (aged 40 years and older) living with dementia worldwide is expected to nearly triple, from an estimated 57 million in 2019 to 153 m

Updated on:May 13,2024

CKD linked to greater neuromuscular fatigability

by Elana Gotkine HealthDay ReporterChronic kidney disease (CKD) is associated with greater neuromuscular fatigability, which increases with fatigue severity, according to a study published online Dec.

Updated on: January 21,2024

CKD linked to greater neuromuscular fatigability

by Elana Gotkine HealthDay ReporterChronic kidney disease (CKD) is associated with greater neuromuscular fatigability, which increases with fatigue severity, according to a study published online Dec.

Updated on:January 21,2024

Possible mechanism for fold formation in the cerebral cortex discovered

by Elena Garrido,Miguel Hernandez University of ElcheImage of a ferret brain showing the altered folding pattern (left) mediated by the Cux2 protein. Credit: IN-CSIC-UMH.Determining the genetic

Updated on: June 15,2024

Possible mechanism for fold formation in the cerebral cortex discovered

by Elena Garrido,Miguel Hernandez University of ElcheImage of a ferret brain showing the altered folding pattern (left) mediated by the Cux2 protein. Credit: IN-CSIC-UMH.Determining the genetic

Updated on:June 15,2024

Counting from left to right feels 'natural,' but new research shows our brains count faster from bottom to top

by Luke Greenacre, Adrian Dyer, Jair Garcia and Scarlett Howard,The ConversationTesting how participants show preferences for either horizontal or vertical mental number lines by indicating the

Updated on: February 18,2024

Counting from left to right feels 'natural,' but new research shows our brains count faster from bottom to top

by Luke Greenacre, Adrian Dyer, Jair Garcia and Scarlett Howard,The ConversationTesting how participants show preferences for either horizontal or vertical mental number lines by indicating the

Updated on:February 18,2024

Dementia care in Australia 'fragmented, challenging to navigate and hard to access'

by Medical Journal of Australia (MJA)Credit: CC0 Public DomainAustralia "does not currently meet the human rights of people with dementia to timely and accessible health services of appropriate q

Updated on: April 25,2024

Dementia care in Australia 'fragmented, challenging to navigate and hard to access'

by Medical Journal of Australia (MJA)Credit: CC0 Public DomainAustralia "does not currently meet the human rights of people with dementia to timely and accessible health services of appropriate q

Updated on:April 25,2024

Interfering with antiviral pathway may deter Alzheimer's disease and frontotemporal dementia

by Weill Cornell Medical CollegeThe cGAS–STING pathway is activated in the hippocampi of mice with tauopathy and in human AD brains. Credit:Nature Neuroscience(2023). DOI: 10.1038/s41

Updated on: June 04,2024

Interfering with antiviral pathway may deter Alzheimer's disease and frontotemporal dementia

by Weill Cornell Medical CollegeThe cGAS–STING pathway is activated in the hippocampi of mice with tauopathy and in human AD brains. Credit:Nature Neuroscience(2023). DOI: 10.1038/s41

Updated on:June 04,2024

Mapping the human brain's default mode network: Anatomical study suggests it has widespread influence

Updated on: March 02,2025

Mapping the human brain's default mode network: Anatomical study suggests it has widespread influence

Updated on:March 02,2025

FDA approves Vyalev for advanced Parkinson's disease

by Lori SolomonThe U.S. Food and Drug Administration has approved AbbVie's Vyalev (foscarbidopa and foslevodopa) for adults living with advanced Parkinson's disease (PD).Vyalev is the first an

Updated on: November 07,2024

FDA approves Vyalev for advanced Parkinson's disease

by Lori SolomonThe U.S. Food and Drug Administration has approved AbbVie's Vyalev (foscarbidopa and foslevodopa) for adults living with advanced Parkinson's disease (PD).Vyalev is the first an

Updated on:November 07,2024